Connect with us

Buyers Speak

COVID is attacking the brain

Cases of neurologic disorders have increased in patients who have recovered from COVID in India. These include brain fog, GB syndrome, headache, paralysis and venous strokes, epilepsy or fainting, encephalitis, demyelization or peeling of nerves, weakening of the nerves of the brain, etc.

The problem of neurological disorders is coming to the fore in a large number of patients who have been cured of COVID in the country. The special thing is that many disorders are with such common symptoms that it becomes difficult to even recognize that it is a disorder born after COVID. Headache is one of these. Experts say that a common headache can be a neurological disorder.

Neurological problems were first seen abroad after the arrival of COVID, but now in India too, cases of neurological disorders are coming to the fore in people recovering from COVID. Cases of brain fog or memory fog are coming to the fore, in which the patient’s memory becomes poor. He also has to face difficulties in accounting. In this, the major functions of the patient’s brain, such as thinking, understanding, and remembering are disturbed. Along with this, the problem of mild seizures also arises. In this, the central nervous system does not work properly. Mental fatigue and confusion persist. It also affects decision-making ability.

Brain hemorrhages and 50 percent of other neurological problems are increasing dangerously in patients who have recovered from COVID.

In some studies, it has been found that patients recovering from coronavirus infection have to suffer from many diseases even later. In such a situation, the problems of these patients increase more than before.

Meanwhile, a Delhi hospital has reported that neurological problems are seen to be increasing dangerously in patients recovering from COVID infection.

The prevalence of such cases is more in those people who had contracted COVID infection in the first two-three months. According to the report, symptoms like headache have been found in 37 percent of the patients. At the same time, symptoms like loss of smell and taste are seen in 26 percent of the patients.

In these patients, in general, 49 percent have acute encephalopathy, 17 percent coma, and 6 percent stroke-like symptoms. There is an increased risk of death in hospitals due to such diseases. The COVID-19 epidemic is not only causing lung disease but also neurological problems for a long time.

About 60 percent of the patients coming to the OPD are suffering from stress, loneliness, and suicidal thoughts. Most of them have had COVID infection before.

Many such critical cases were also reported in AIIMS, Delhi, in which patients were paralyzed during COVID itself. At the same time, there were some who got paralyzed after recovering from COVID. During this, the blood vessels of the patients either got blocked, or burst, or there was a problem of clotting of blood, which is also called, venous strokes.

During this, blood accumulates in the veins, which leads to paralysis. During the COVID wave, beds used for patients of other diseases were also reserved for COVID patients, but as soon as COVID cases reduced, a large number of patients of other diseases came to the fore, out of which there were also patients suffering from neuro problems. In many cases, patients did even survive, while some became critical.

A growing number of case reports and series describe a wide array of neurological manifestations in 901 patients, but many have insufficient details, reflecting the challenge of studying such patients. Encephalopathy has been reported for 93 patients in total, including 16 (7%) of 214 hospitalized patients with COVID-19 in Wuhan, China, and 40 (69%) of 58 patients in intensive care with COVID-19 in France. Encephalitis has been described in eight patients to date, and Guillain-Barré syndrome in 19 patients. SARS-CoV-2 has been detected in the CSF of some patients. Anosmia and ageusia are common, and can occur in the absence of other clinical features.

Unexpectedly, acute cerebrovascular disease is also emerging as an important complication, with cohort studies reporting stroke in 2–6 percent of patients hospitalized with COVID-19.

So far, 96 patients with stroke have been described, who frequently had vascular events in the context of a pro-inflammatory hyper­coagulable state with elevated C-reactive protein, D-dimer, and ferritin.

For those who are already suffering from neuro-related diseases and have come under the grip of COVID, the reason for such problem is also the medicines given in diseases related to the brain. Most of the drugs given in brain diseases are such that they eliminate or control the original disease of the patient, but have a bad effect on the patient’s immunity.

Careful clinical, diagnostic, and epidemiological studies are needed to help define the manifestations and burden of neurological disease caused by SARS-CoV-2. Precise case definitions must be used to distinguish non-specific complications of severe disease (e.g., hypoxic encephalopathy and critical care neuropathy) from those caused directly or indirectly by the virus, including infectious, para-infectious, and post-infectious encephalitis, hypercoagulable states leading to stroke, and acute neuropathies, such as Guillain-Barré syndrome.

Recognition of neurological disease associated with SARS-CoV-2 in patients, whose respiratory infection is mild or asymptomatic, might prove challenging, especially if the primary COVID-19 illness occurred weeks earlier.

The proportion of infections leading to neurological disease will probably remain small. However, these patients might be left with severe neurological sequelae.

With so many people infected, the overall number of neurological patients, and their associated health burden and social and economic costs might be large. Healthcare planners and policy makers must prepare for this eventuality, while many ongoing studies investigating neurological associations increase our knowledge base.

Researchers who conducted the analysis said that it is not yet clear how the virus is linked to psychiatric conditions, such as anxiety and depression. But these were the most common diseases among those 14 diseases, which were seen in the patients. Researchers said that post-Covid cases such as stroke, dementia, and neurological disorders were extremely rare. But these were especially important for patients seriously suffering from COVID.

Coronavirus is affecting people both physically and mentally. Due to new mutations in the virus, people are facing various problems.

In a recent study, scientists have reported that due to coronavirus, a serious neurological problem is being seen in people. Scientists say that people recovering from COVID-19 need special care and monitoring, because the virus is causing serious brain damage.

Experts say that this study can help to get better information about the short- and long-term effects of COVID-19 on neurological health.

  • Since COVID is also causing many types of mental problems, it is very important to take care of these things:
  • If you have a dementia patient at home, take special care of him.
  • Keep COVID-friendly behavior, get them vaccinated so that they can avoid this infection.
  • In case of infection, do not treat at home without medical advice.
  • Keep trying to keep the patient’s blood pressure and sugar level under control.

Copyright © 2024 Medical Buyer

error: Content is protected !!